Upload date
All time
Last hour
Today
This week
This month
This year
Type
All
Video
Channel
Playlist
Movie
Duration
Short (< 4 minutes)
Medium (4-20 minutes)
Long (> 20 minutes)
Sort by
Relevance
Rating
View count
Features
HD
Subtitles/CC
Creative Commons
3D
Live
4K
360°
VR180
HDR
17,502,881 results
The Investment Committee gives you their top stocks to watch for the second half.
4,035 views
4 weeks ago
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss the data from its phase three trial of a combination flu and ...
2,352 views
9 days ago
Moderna's second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the ...
1,976 views
1 month ago
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss the company's annual vaccines day, the announcement of multiple ...
3,926 views
2 months ago
Moderna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines.
1,216 views
CNBC's Angelica Peebles joins 'Power Lunch' to report on Moderna's experimental cancer vaccine.
3,456 views
6 months ago
CNBC's Jim Cramer explains why he is keeping an eye on shares of Moderna.
2,628 views
3 months ago
The biotech industry saw reduced IPOs and investment in 2023. Is there reason for optimism? Noubar Afeyan, founder and chief ...
3,025 views
Moderna Inc. reported fourth-quarter revenue that beat analysts' expectations by gaining Covid vaccine market share on its rival, ...
566 views
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss the company's quarterly earnings results, which posted a surprise ...
3,355 views
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss new developments in the treatment for melanoma, after studies ...
3,877 views
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in ...
16,799 views
11 months ago
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss the company's quarterly earnings results, which posted a ...
1,902 views
CNBC's Jim Cramer breaks down a variety of stock during the 'Mad Money' Lightning Round.
3,036 views
3 weeks ago
We see top-line sales for Moderna starting to grow in 2025 with multiple product launches in the next 12 to 18 months, says Hartaj ...
790 views
Moderna's (MRNA) adjusted EPS came in at -$3.07 versus an estimated -$3.59 and revenue came in at $167.00M versus an ...
351 views
5,934 views
7 months ago
WBZ-TV's Dr. Mallika Marshall reports.
266 views
Moderna plans to begin a late-stage trial later this year of its combination vaccines that offer protection against both COVID-19 ...
2,237 views
8 months ago
A Boston doctor discusses a new study that looked at Medicare data from more than 6 million older Americans after they received ...
6,975 views
10 months ago